Mary Lyon Medal 2027 – Dr Raheleh Rahbari

The Genetics Society is delighted to announce Dr Raheleh Rahbari, Wellcome Sanger Institute, as the winner of the 2027 Mary Lyon Medal.

Raheleh Rahbari is a Group Leader at the Wellcome Sanger Institute, where she leads the Genome Evolution, Disease Predisposition and Ageing research group. Her research explores how mutations arise and accumulate throughout human life, how they are shaped by natural selection, and how these processes influence genetic disease, cancer and ageing. Her work brings together human genetics, evolutionary biology and innovative genomic technologies to understand the origins and consequences of genetic variation.

Raheleh has made significant contributions to understanding the origins of new mutations in humans. Her early research helped reveal how mutations arising at different stages of development contribute to genetic variation between generations, providing important insights into germline mosaicism and the origins of genetic disease. More recently, her group has advanced the direct study of mutations in human sperm, demonstrating how mutations accumulate with paternal age and how positive selection favours particular mutations in the male germline. This work has revealed that mutations associated with developmental disorders and cancer can become enriched in sperm as men age, challenging the traditional view that germline mutations are transmitted solely according to their underlying rates of occurrence. These discoveries have important implications for understanding the origins of genetic disorders and reproductive risk.

Alongside her work on germline mutation, Raheleh investigates the accumulation and selection of somatic mutations in normal human tissues. Her research examines how mutant cells expand during development and ageing, how environmental and genetic factors influence these processes, and how clonal evolution contributes to disease predisposition and cancer. By studying mutation and selection across different tissues and stages of life, her group seeks to uncover the fundamental evolutionary principles that govern the behaviour of human cells.

A central feature of Raheleh’s research is the application and development of genomic technologies to investigate biological processes that were previously difficult to observe. Her group combines highly accurate DNA sequencing with single-cell and spatial genomic approaches to study mutation accumulation, clonal dynamics and the relationship between genetic variation and cellular behaviour. By connecting fundamental discoveries in genome evolution with human disease, her research is helping to bridge the gap between mutation biology and clinical genetics.

Raheleh obtained her PhD in Medical Genetics from the University of Leicester in 2011, working with Sir Alec Jeffreys and Richard Badge. She subsequently joined the Wellcome Sanger Institute, where she worked with Matthew Hurles before pursuing research in cancer genomics and somatic evolution with Peter Campbell and Sir Mike Stratton. She was awarded a Cancer Research UK Career Development Fellowship in 2019 and established her independent research programme, becoming a Group Leader at the Wellcome Sanger Institute in 2022. Her research continues to address fundamental questions about how genomes evolve and how mutations shape human health and disease.